
A burst of vitality under the tongue
Formulated with WaferiX® Technology, SL-NAD+ stabilizes and delivers NAD+ as nanoparticles under the tongue.
Rapid Disintegration
Under 60 seconds, take it on the go
Rapid Absorption
Active ingredients delivered directly into the bloodstream
High Bioavailability
Increased & consistent absorption
Faster Onset of Benefits
Clinically proven results
Innovative
delivery technology
WaferiX® is the latest in innovative supplement technology. Our patented sublingual wafer technology features an amorphous, non-ionic, and non-crystalline wafer matrix platform that allows for rapid absorption of multiple active ingredients.
Experience the convenience and efficacy of WaferiX® for yourself.

Superior sublingual absorption
WaferiX® allows active ingredients to bypass the digestive system and be directly absorbed into the bloodstream through tiny blood vessels under the tongue. Entity products which incorporate WaferiX® technology are SL-NAD+ (nicotinamide adenine dinucleotide), LumeniX (glutathione), and WafeRest (melatonin).
Our revolutionary WaferiX® technology ensures that the active ingredients in our products are delivered to your body effectively and rapidly.
Benefits of WaferiX®
Our revolutionary WaferiX® technology ensures that the active ingredients in our products are delivered to your body effectively and rapidly.

Rapid Disintegration
Under 60 seconds, take it on the go

High Bioavailability
Bypasses digestive system for efficient delivery

Rapid Absorption
Feel the difference faster

Alternative to IV
Safe, convenient and accessible to all

Faster Onset of Benefits
No conversion of actives
Technology backed by
Scientific Publications
01
The absolute bioavailability of racemic ketamine from a novel sublingual formulation, British Journal of Clinical Pharmacology, 2013
02
The Pharmacokinetics and Local Tolerability of a Novel Sublingual Formulation of Buprenorphine, Oxford Journal on Pain Medicine, 2017

Patents
Our products and methods are patented in all key markets, including Australia, China, India, Japan, South Korea, Hong Kong SAR, Macau SAR, European Union (Germany, France, United Kingdom, Italy, Spain, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium, Austria, Norway, Denmark, Ireland and Finland), Canada, South Africa, New Zealand, Singapore, Malaysia, Vietnam, Indonesia, USA and Israel.